TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07144150: EVERO Drug-coated Balloon (DCB) Randomized Trial

Sponsor: Cook Research Incorporated · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 410 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$8,565,600

Rescue Site Savings

+$5,644,000

Unlock Full NCT07144150 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07144150 Rescue Dossier →